Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
65.33 Down 0.98(1.48%) Apr 17, 4:00PM EDT
|After Hours : 65.45 Up 0.12 (0.18%) Apr 17, 7:41PM EDT
Add to Portfolio
Prev Close:66.31
Open:65.20
Bid:65.40 x 100
Ask:67.50 x 1000
1y Target Est:65.80
Beta:1.32
Earnings Date:May 4 - May 8 (Est.)
Day's Range:64.61 - 66.20
52wk Range:22.25 - 77.80
Volume:2,064,845
Avg Vol (3m):2,872,830
Market Cap:7.78B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 1.48%7.78B
ENZUp 1.50%122.51M
GILDDown 1.90%151.00B
SRPTDown 1.71%546.96M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.82
Quarterly EPS Est (Mar-15) :-0.21
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-3.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback